Compare Antengene Corporation Limited (722) vs. Competitors

0 Followers

Comparison Results

722

Antengene Corporation Limited

€0.53

€242.44M

34.01

-49.93%

1 Buy

0 Hold

0 Sell

Moderate Buy

Innovent Biologics

HK$100.10

HK$161.76B

111.73

-11.56%

19 Buy

0 Hold

0 Sell

Strong Buy

Alphamab Oncology

HK$11.90

HK$7.35B

-36.49

-48.71%

―

Shanghai Junshi Biosciences Co., Ltd. Class H

HK$27.54

HK$34.47B

-78.89

-44.75%

2 Buy

1 Hold

0 Sell

Moderate Buy

CStone Pharmaceuticals

HK$5.34

HK$8.25B

-16.08

-36.10%

1 Buy

0 Hold

0 Sell

Moderate Buy

Ascentage Pharma Group International

HK$50.90

HK$10.42B

-6.19

-64.12%

1 Buy

0 Hold

0 Sell

Moderate Buy

xxxxxxxxxxxxx

722 vs 6855

xxxxxxxxxxxxx

Performance Comparison

DE:722

Antengene Corporation Limited

0.36

-0.28

-43.62%

HK:1801

Innovent Biologics

92.60

-1.35

-1.44%

HK:9966

Alphamab Oncology

7.54

-5.52

-42.27%

HK:1877

Shanghai Junshi Biosciences Co., Ltd. Class H

17.46

-12.12

-40.97%

HK:2616

CStone Pharmaceuticals

5.24

-1.56

-22.94%

HK:6855

Ascentage Pharma Group International

28.02

-44.48

-61.35%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >